Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Shanghai Smith Adhesive New Material Co., Ltd (603683.SS)
Shanghai, CN
Founded in 2006 and based in Shanghai, China, Shanghai Smith Adhesive New Material Co., Ltd specializes in the production and distribution of a diverse range of adhesive tapes. Within China, these products are marketed under the Ginnva brand. Their comprehensive catalog encompasses items such as masking, duct, rice paper, electronics, foam, aluminum foil, and kraft paper tapes, alongside various BOPP tapes, including those designed for packaging and stationery use. These adhesive solutions are vital for numerous sectors, including electronics, new materials, office supplies, packaging, warning labels, the automotive industry, and hardware construction. The company also maintains a global presence, exporting its merchandise to nearly 50 countries across regions like Southeast Asia, the Middle East, Europe, South America, and Africa.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.04% | +0.74% | -5.09% | +10.75% | +4.58% | +7.11% | +91.21% | +159.96% | +222.73% | +242.07% | +242.07% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2025-12 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+15.1% ★ Q1'26: +21.1% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+19.2% ★ Q1'26: +22.2% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+2.7% Q1'26: -14.2% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+4.8% Q1'26: +3.0% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+5.0% Q1'26: +2.6% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+13.1% Q1'26: +11.3% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×3.33× Q1'26: 14.49× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. |
|---|---|---|---|
| Revenue |
2.17B
est: 2.22B (-2.1%)
|
2.53B
2.53B – 2.53B
+14.2% YoY
|
2.94B
2.94B – 2.94B
+15.9% YoY
|
| EBITDA |
193.27M
est: 196.41M (-1.6%)
|
224.39M
224.39M – 224.39M
+14.2% YoY
|
260.08M
260.08M – 260.08M
+15.9% YoY
|
| EBIT |
103.37M
est: 101.89M (+1.5%)
|
116.41M
116.41M – 116.41M
+14.2% YoY
|
134.92M
134.92M – 134.92M
+15.9% YoY
|
| Net Income |
89.32M
est: 81.67M (+9.4%)
|
105.01M
105.01M – 105.01M
+28.6% YoY
|
—
— – —
-100.0% YoY
|
| SGA |
62.37M
est: 134.38M (-53.6%)
|
153.52M
153.52M – 153.52M
+14.2% YoY
|
177.94M
177.94M – 177.94M
+15.9% YoY
|
| EPS |
0.31
est: 0.28 (+10.7%)
|
0.36
0.36 – 0.36
+28.6% YoY
|
—
— – —
-100.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C+ | 2/5 | 2/5 | 3/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-28 | C+ | 2/5 | 2/5 | 3/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-27 | C+ | 2/5 | 2/5 | 3/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-26 | C+ | 2/5 | 2/5 | 3/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-25 | C+ | 2/5 | 2/5 | 3/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-22 | C+ | 2/5 | 2/5 | 3/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-21 | C+ | 2/5 | 2/5 | 3/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-20 | C+ | 2/5 | 2/5 | 3/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-19 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-18 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-15 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C+ | 2/5 | 3/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | B- | 2/5 | 3/5 | 3/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-06 | B- | 2/5 | 3/5 | 3/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-30 | B- | 3/5 | 3/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-29 | B- | 3/5 | 3/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-28 | B- | 3/5 | 3/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-27 | B- | 3/5 | 3/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-24 | B- | 3/5 | 3/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-23 | B- | 3/5 | 3/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-22 | B- | 3/5 | 3/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-21 | B- | 3/5 | 3/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-20 | B- | 2/5 | 3/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Aining Lin | Accounting Supervisor | — | — |
| Li Yin | Financial Director | — | male |
| Qiumei Bai | Director & Deputy GM | — | female |
| Shusheng Wang | Deputy General Manager | — | male |
| Xiaochan Pan | Secretary of the Board of Directors | — | female |
| Xiaodong Zhou | Vice Chairman of the Board of Directors & Deputy GM | — | male |
| Xiaonan Zhou | Chairman of the Board of Directors & GM | — | male |
| Zhangqin Zheng | Deputy General Manager | — | male |
| Zhonghui Zhou | Deputy General Manager | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 603683.SS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
